News Conference News AHA 2014 Long-Term Better than Short-Term Prasugrel After PES Stenting November 15, 2014
News Conference News TCT 2014 Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
News Conference News TCT 2014 PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI September 15, 2014
News Conference News TCT 2014 Expert Discusses Potential Role for Platelet Function, Genetic Testing September 15, 2014
News Conference News TCT 2014 Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES Todd Neale September 13, 2014
News Conference News ESC 2014 ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall Todd Neale September 08, 2014
News Conference News ESC 2014 ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients Yael L. Maxwell September 03, 2014
News Conference News ESC 2014 ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration Yael L. Maxwell September 01, 2014
News Conference News ACC 2014 HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues Jason Kahn March 31, 2014
News Conference News ACC 2014 GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI Jason Kahn March 31, 2014
News Conference News ACC 2014 EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI Jason Kahn March 29, 2014
News Conference News TCT 2013 Studies Find Differing Benefits of Platelet, Genotype Testing October 31, 2013
News Conference News TCT 2013 EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI October 30, 2013
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis Yael L. Maxwell September 03, 2013
News Conference News ESC 2013 TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS Caitlin E. Cox September 01, 2013
News Conference News ESC 2013 ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS Yael L. Maxwell September 01, 2013
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012
News Conference News AHA 2012 Platelet Reactivity in Response to Prasugrel Depends on the Test November 04, 2012
News Conference News AHA 2012 TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes November 04, 2012